Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/10/832   
Active ingredient: Deferiprone
Indication: Treatment of sickle cell disease
Sponsor: Apotex Europe B.V.
Archimedesweg 2, 2333 CN Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/03/2011 Orphan designation EMA/OD/077/10 (2011)1298 of 23/02/2011
20/02/2018 Change of name and/or address of sponsor